BridgeMD
New treatment option for Heart Surgery
Official title Evaluation of Virtual Reality for Reducing Opioid Use After Cardiac and Thoracic Surgery
ClinicalTrials.gov ID: NCT07063394
What this study is testing
- What it's testing
- This clinical trial aims to evaluate the efficacy of virtual reality (VR) as an adjunctive therapeutic method to reduce opioid consumption during the postoperative period of cardiac and thoracic surgeries. Conducted at InCor/HCFMUSP, this single-center, prospective, randomized trial will include 60 patients aged 16 to 40 undergoing procedures such as valve replacements, pulmonary decortication, and video-assisted thoracic surgeries.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 40
You may be able to join if
- Patients undergoing elective cardiac or thoracic surgeries at the Heart Institute (InCor) of the Hospital das Clínicas of the University of São Paulo.
- Eligible thoracic surgeries include: pulmonary decortication, thoracic sympathectomy, video-assisted thoracoscopic surgery (VATS), pulmonary biopsy...
- Patients aged between 16 and 40 years.
- Preserved cognitive function, indicated by a Mini-Mental State Examination (MMSE) score of ≥ 25.
You likely can't join if
- Visual impairments.
- Cognitive impairment (MMSE ≤ 24).
- Severe upper limb motor limitations.
- Claustrophobia.
- Spatial disorientation.
- Motion sickness or vestibular disorders.
See the full eligibility criteria
- Patients undergoing elective cardiac or thoracic surgeries at the Heart Institute (InCor) of the Hospital das Clínicas of the University of São Paulo.
- Eligible thoracic surgeries include: pulmonary decortication, thoracic sympathectomy, video-assisted thoracoscopic surgery (VATS), pulmonary biopsy, and pectus excavatum repair using the Nuss procedure.
- Patients aged between 16 and 40 years.
- Preserved cognitive function, indicated by a Mini-Mental State Examination (MMSE) score of ≥ 25.
- Visual impairments.
- Cognitive impairment (MMSE ≤ 24).
- Severe upper limb motor limitations.
- Claustrophobia.
- Spatial disorientation.
- Motion sickness or vestibular disorders.
- Infectious or contagious diseases.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.